MSL
ATRA icon

Mackay Shields LLC’s Atara Biotherapeutics ATRA Stock Holding History

Mackay Shields LLC’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,820
Closed -$653K – 760
2021
Q1 		$653K Sell
1,820
-961
-35% -$425K ﹤0.01% 1130
2020
Q4 		$1.36M Sell
2,781
-564
-17% -$260K 0.01% 987
2020
Q3 		$1.08M Sell
3,345
-516
-13% -$176K 0.01% 1007
2020
Q2 		$1.41M Buy
3,861
+512
+15% +$129K 0.01% 905
2020
Q1 		$713K Buy
3,349
+492
+17% +$156K 0.01% 1052
2019
Q4 		$1.18M Buy
2,857
+164
+6% +$56.5K 0.01% 1036
2019
Q3 		$951K Buy
2,693
+564
+26% +$210K 0.01% 1126
2019
Q2 		$1.07M Buy
2,129
+1,489
+233% +$1.05M 0.01% 1105
2019
Q1 		$636K Buy
640
+20
+3% +$18.6K ﹤0.01% 1122
2018
Q4 		$538K Buy
+620
New +$576K ﹤0.01% 1124
2018
Q3 		– Sell
-536
Closed -$493K – 1136
2018
Q2 		$493K Buy
+536
New +$576K ﹤0.01% 1102

Other funds holding ATRA

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return